個案總覽

Piaggio, manufacturer of the Vespa motor scooter, faces the decision of whether to outsource production of a new engine. The decision in the A case is couched in uncertainty over the achievable sales volume for the engine, particularly as new and less expensive competitor products are gaining popularity. The case provides an overview of the competitive style of each of the major manufacturers and allows a discussion of core capabilities of these competitors. The B case describes what happens in the market and to Piaggio after the company has built the engine.

This case focuses on the creation of a work plan for a consulting engagement.

The quality of both strategic thinking and action rely, in important ways, on the quality of the strategic conversations underway at all levels in the organization. The design of these conversations is the defining contribution of the strategy-making process. When these strategic conversations about the design of the future operate successfully at both local and organizational levels, they create a "meta-capability" for strategy-making capable of both furthering intended strategy and for recognizing opportunities for emergent strategy.

In this case, Copeland executives have hired Bain & Company, a management-consulting firm, to make recommendations about a capital-appropriations request. A teaching note is available to registered faculty, along with a video supplement to enhance student learning.

This case focuses on the development of AZT, the first drug approved for the treatment of AIDS, and the issues faced by its U.K. producer, Wellcome PLC, as it decides how to set the drug's price. The case includes brief overviews of the disease itself, drugs in development to treat it, the pharmaceutical industry and its practices, and the history of Wellcome PLC and its U.S. subsidiary, Burroughs Wellcome. The A case concludes with analysts' predictions for the soon-to-be-announced price of AZT. See also the B case and the C case.